Table 1.
Baseline characteristics | Column No. (%) Mean (SD) |
P Value | ||||
---|---|---|---|---|---|---|
WIHS (N = 1744) |
MACS (N = 980) |
|||||
HIV− (n = 552) |
HIV+ (n = 1192) |
P Value | HIV− (n = 386) |
HIV+ (n = 594) |
||
Race | .005 | <.001 | ||||
White | 93 (17) | 277 (23) | 257 (67) | 307 (52) | ||
African American/black | 370 (67) | 713 (60) | 105 (27) | 226 (38) | ||
Other | 89 (16) | 202 (17) | 24 (6) | 61 (10) | ||
Annual income, $ | .001 | <.001 | ||||
<$10,000 | 232 (42) | 612 (51) | 65 (17) | 157 (26) | ||
$10,000–$30,000 | 206 (37) | 385 (32) | 85 (22) | 211 (36) | ||
≥$30,000 | 114 (21) | 195 (16) | 236 (61) | 226 (38) | ||
Receipt of mental health services | <.001 | <.001 | ||||
No | 495 (90) | 939 (79) | 341 (88) | 465 (78) | ||
Yes | 57 (10) | 253 (21) | 45 (12) | 129 (22) | ||
Alcohol consumptiona | <.001 | .04 | ||||
<1 drink/week | 219 (40) | 630 (53) | 43 (11) | 92 (16) | ||
1–7 [14] drinks/week | 275 (50) | 483 (40) | 312 (81) | 471 (79) | ||
>7 [14] drinks/week | 58 (11) | 79 (7) | 31 (8) | 31 (5) | ||
Illicit drug useb | <.001 | .01 | ||||
No | 321 (69) | 955 (80) | 316 (84) | 441 (77) | ||
Yes | 141 (30) | 237 (20) | 62 (16) | 131 (23) | ||
Framingham risk score, mean (SD) | 8.1 (6.8) | 8.7 (5.9) | .08 | 13.4 (1.6) | 13.5 (1.6) | .23 |
Ever diagnosed as having diabetes | .54 | .02 | ||||
No | 416 (75) | 882 (74) | 227 (72) | 384 (65) | ||
Yes | 136 (25) | 310 (26) | 109 (38) | 210 (35) | ||
Body mass index, mean (SD) | 30.5 (4.8) | 29.4 (10.5) | .002 | 26.6 (4.1) | 25.5 (3.7) | <.001 |
HIV RNA suppressionc | NA | NA | ||||
Suppressed (<200 copies/mL) | 539 (45) | 417 (70) | ||||
Unsuppressed (≥200 copies/mL) | 653 (55) | 177 (30) | ||||
CD4+ T-cell countc | NA | NA | ||||
≥500 cells/mm3 | 452 (38) | 260 (44) | ||||
300–500 cells/mm3 | 342 (29) | 156 (26) | ||||
<300 cells/mm3 | 398 (33) | 178 (30) | ||||
Cumulative ART exposure, mean years (SD)c | NA | 5.8 (2.6) | NA | 7.2 (2.8) | ||
Depressive risk pattern | <.001 | <.001 | ||||
Low | 319 (58) | 335 (45) | 202 (52) | 201 (34) | ||
Moderate | 174 (31) | 366 (31) | 58 (15) | 201 (34) | ||
High | N/A | 304 (25) | 89 (23) | 130 (22) | ||
Decreased | N/A | 79 (7) | N/A | N/A | ||
Severe | 59 (11) | 108 (9) | 37 (10) | 62 (10) |
WIHS women’s interagency HIV study, MACS multicenter AIDS cohort study, ART antiretroviral therapy
1–7 drinks/week for women, 1–14 drinks/week for men; >7 drinks/week for women, >14 drinks/week for men
Includes crack cocaine, other forms of cocaine, methamphetamines (speed, meth, or ice), and ecstasy
Among HIV-seropositive participants only